AKERO THERAPEUTICS INC (AKRO) Forecast, Price Target & Analyst Ratings

NASDAQ:AKRO • US00973Y1082

Current stock price

54.65 USD
+0.1 (+0.18%)
At close:
54.7 USD
+0.05 (+0.09%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AKERO THERAPEUTICS INC (AKRO).

Forecast Snapshot

Consensus Price Target

Price Target
$64.26
+ 17.58% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Feb 26, 2026
Period
Q4 / 2025
EPS Estimate
-$0.96
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
72.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$64.26
Upside
+ 17.58%
From current price of $54.65 to mean target of $64.26, Based on 16 analyst forecasts
Low
$54.54
Median
$59.16
High
$114.45

Price Target Revisions

1 Month
0.00%
3 Months
-15.18%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for AKRO. The average price target is 64.26 USD. This implies a price increase of 17.58% is expected in the next year compared to the current price of 54.65.
The average price target has been revised downward by 15.18% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

AKRO Current Analyst RatingAKRO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

AKRO Historical Analyst RatingsAKRO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
72.50%
AKRO was analyzed by 16 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about AKRO.
In the previous month the buy percentage consensus was at a similar level.
AKRO was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-10-10Wolfe ResearchDowngrade Outperform -> Peer Perform
2025-10-10HC Wainwright & Co.Downgrade Buy -> Neutral
2025-10-09Canaccord GenuityDowngrade Buy -> Hold
2025-10-09JefferiesDowngrade Buy -> Hold
2025-08-04TD CowenInitiate Buy
2025-05-27B of A SecuritiesMaintains Buy -> Buy
2025-05-13CitigroupMaintains Buy -> Buy
2025-03-03HC Wainwright & Co.Maintains Buy -> Buy
2025-01-31UBSMaintains Buy -> Buy
2025-01-30B of A SecuritiesUpgrade Neutral -> Buy
2025-01-28Canaccord GenuityMaintains Buy -> Buy
2025-01-28Morgan StanleyMaintains Overweight -> Overweight
2025-01-28CitigroupMaintains Buy -> Buy
2025-01-27HC Wainwright & Co.Maintains Buy -> Buy
2025-01-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-18CitigroupInitiate Buy
2024-11-18HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-17HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-12HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-20Cantor FitzgeraldReiterate Overweight
2024-06-12Cantor FitzgeraldReiterate Overweight
2024-06-11Wolfe ResearchInitiate Outperform
2024-06-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-15Evercore ISI GroupMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Feb 26, 2026
Period
Q4 / 2025
EPS Estimate
-$0.96
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
3.15%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
4.20%
EPS (3 Months)
1.05%

Next Earnings Summary

AKRO is expected to report earnings on 2/26/2026. The consensus EPS estimate for the next earnings is -0.96 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
AKRO revenue by date.AKRO revenue by date.
N/AN/AN/AN/AN/A
364.77%		N/A
138.25%		N/A
82.48%		N/A
-13.38%
EBITDA
YoY % growth
AKRO ebitda by date.AKRO ebitda by date.
N/AN/AN/A-80.13M
-73.23%		-100.85M
-25.86%		-115.12M
-14.15%		-172.841M
-50.14%		-285.405M
-65.13%		N/A
-24.11%		N/A
-8.97%		N/A
-5.26%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
AKRO ebit by date.AKRO ebit by date.
-4.56M-13.78M
-202.19%		-45.65M
-231.28%		-80.15M
-75.58%		-100.89M
-25.88%		-115.16M
-14.14%		-172.87M
-50.11%		-285.423M
-65.11%		N/A
-21.08%		N/A
-13.12%		N/A
-9.87%		N/A
20.72%		N/A
121.87%		N/A
796.96%		N/A
127.08%		N/A
-31.51%
Operating Margin
AKRO operating margin by date.AKRO operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
AKRO eps by date.AKRO eps by date.
N/AN/AN/A-2.48
13.42%		-2.89
-16.53%		-2.92
-1.04%		-2.85
2.40%		-3.75
-31.58%		N/A
-1.02%		N/A
-16.05%		N/A
-4.78%		N/A
39.25%		N/A
175.64%		N/A
335.42%		N/A
94.85%		N/A
-51.66%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.96
3.15%		-1.00
-10.69%		-1.03
-19.40%		-1.05
-7.55%		-1.10
-14.89%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-94.804M
-21.53%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-90.847M
-16.43%		-93.005M
-14.99%		-95.407M
-17.97%		-97.996M
-8.60%		-98.022M
-7.90%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AKRO Yearly Revenue VS EstimatesAKRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
AKRO Yearly EPS VS EstimatesAKRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 10 15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-7.10%
EPS Next 5 Year
20.73%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-10.65%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AKERO THERAPEUTICS INC / AKRO Forecast FAQ

What do analysts expect the price target to be for AKERO THERAPEUTICS INC (AKRO)?

16 analysts have analysed AKRO and the average price target is 64.26 USD. This implies a price increase of 17.58% is expected in the next year compared to the current price of 54.65.

Can you provide the upcoming earnings date for AKERO THERAPEUTICS INC?

AKERO THERAPEUTICS INC (AKRO) will report earnings on 2026-02-26, after the market close.

Can you provide the consensus estimates for AKERO THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of AKERO THERAPEUTICS INC (AKRO) is -0.96 USD and the consensus revenue estimate is 0 USD.

How many analysts cover AKERO THERAPEUTICS INC (AKRO) stock?

The number of analysts covering AKERO THERAPEUTICS INC (AKRO) is 16.